Cell Communication and SignalingCancer BiologyPeer-reviewed journal article
SATB2 and circ3915 RNA chromatin dysregulation drive KRAS-like oncogenic transformation
Rebekah EleazeriD, Smitha GeorgeiD, Luke J. Shoemaker, Wesley N. SaintilnordiD, Richard N CassidyiD, Andrew PymaniD, Kin Lau, Molly T. Soper-HopperiD, Hyoungjoo LeeiD, Darrell P. ChandleriD, Yvonne N. Fondufe‐MittendorfiD
Abstract
Even though epigenetic factors contribute to oncogenesis, most human cancer models still assume that disease originates from driver DNA mutations. Thus, it is still unclear if non-genetic mechanisms are sufficient to trigger malignant transformation. Special AT-rich binding protein 2 (SATB2) is a chromatin organizer that brings distal DNA elements into close proximity, thus remodeling chromatin structures to reprogram cell-specific and/or developmentally-sensitive gene networks. Here, we discover that SATB2 generates a co-expressed circ3915 RNA that is translated into a peptide and co-locates with SATB2 in the cell nucleus. Ectopic SATB2 or circ3915 over- expression rearranges global chromatin accessibility, generates KRAS- and NFE2L2-like oncogenic gene expression patterns, and transforms lung epithelial cells independent of driver mutations. Thus, oncogenic pathways can be activated in mammalian cells without pre-disposing mutations in oncogenes or epigenetic regulators. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=153 SRC="FIGDIR/small/616681v1_ufig1.gif" ALT="Figure 1000"> View larger version (32K): org.highwire.dtl.DTLVardef@1314b69org.highwire.dtl.DTLVardef@14df9e1org.highwire.dtl.DTLVardef@505bddorg.highwire.dtl.DTLVardef@1bf3fab_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: ChIP-seq
- assay: bulk RNA-seq
- research focus: cancer & tumor microenvironment
- research focus: chromatin & epigenetic regulation
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 1
- FWCI
- 0.00
- Field percentile
- 34th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genomic Retargeting of Tumor Suppressors p53 and CTCF Promotes Oncogenesis
M. Schwartz, A. Sarusi Portugez, … O. Hakim·bioRxiv·Jul 23, 2019
- SETDB1 Fuels the Lung Cancer Phenotype by Modulating Epigenome, 3D Genome Organization and Chromatin Mechanical Properties
V. Zakharova, M. Magnitov, … S. Ait-Si-Ali·bioRxiv·Sep 6, 2021
- Satb2 acts as a gatekeeper for major developmental transitions during early vertebrate embryogenesis
Saurabh J. Pradhan, Puli Chandramouli Reddy, … Sanjeev Galande·Nature CommunicationsPeer-reviewed·Oct 19, 2021
- Runx3 Acts as Homodimeric Chromatin Binding Factor Regulating Heterochromatin-Mediated Cancerous Phenotype
Salma Mahmoud Awad, Isabelle Bonne, … Gehan Labib Abuelenain·bioRxiv·Aug 16, 2024
- SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model and its catalytic activity is regulated by histone acetylation
Ricardo J Mack, Natasha Mahealani Flores, … Or Gozani·eLifePeer-reviewed·Sep 15, 2025
- RAS and PP2A activities converge on epigenetic gene regulation
A. Aakula, M. Sharma, … J. Westermarck·bioRxiv·May 11, 2022